Calculated Bounce

Relay Therapeutics is currently testing the bottom of a key daily gap near the $7.00 level, an area that often acts as a magnet for price and a potential reversal zone. It would not be surprising to see RLAY briefly fill this gap and tag the 150-day SMA before the next leg higher, which would further strengthen the base.

A decisive breakout above the $9.04 level would confirm renewed bullish momentum and open the door for a move toward the $12.06 resistance, offering solid upside from current levels.

RLAY appears ready for a bounce after recently tagging and holding its $1 billion market cap level. When a stock successfully defends this valuation threshold, it often signals institutional and long-term investor interest stepping in. If a company is going to survive and grow, bouncing off the $1B market cap is a healthy and constructive sign.

With a clearly defined stop loss at $5.16, this setup offers an excellent risk-to-reward ratio, making RLAY an attractive biotech rebound play.